SOURCE: HealthSonix, Inc.

September 20, 2006 08:00 ET

HealthSonix Now Trading on Frankfurt Stock Exchange

IRVINE, CA -- (MARKET WIRE) -- September 20, 2006 -- HealthSonix Inc. (PINKSHEETS: HSXI) (XETRA: H7S) today announced that its shares are now trading on the "XETRA" Frankfurt Stock Exchange. Trading symbol is H7S.

"European investors can now invest in HealthSonix on a European exchange and obtain quotes in Euros," stated Dieter Doederlein, Vice President of Corporate Development. "Our medical technology and treatment programs are receiving world wide attention. German patients suffering from the pain of arthritis have always been more interested in non-pharmacologic treatment programs, such as the ones offered by HealthSonix."

RG SECURITIES AG, a major German investment banking and brokerage firm, facilitated the Frankfurt listing. RG SECURITIES will also act as the Company's market maker and a local specialist on the German exchange.

The Frankfurt Stock Exchange (German: FWB R Frankfurter Wertpapierbörse) is the largest stock exchange in Germany. It is owned and operated by Deutsche Börse AG, which also owns the European futures exchange, EUREX, and the Clearstream clearing company. The Frankfurt Stock Exchange executes over 90 percent of the transactions in the German market and represents a substantial share of the overall European market.

HealthSonix, Inc. (PINKSHEETS: HSXI) (XETRA: H7S) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.

More information regarding HealthSonix and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information